Publicaciones en colaboración con investigadores/as de Hospital Vall d'Hebron (105)

2023

  1. A Study of the Prevalence of Asthma in the General Population in Spain

    Open Respiratory Archives, Vol. 5, Núm. 2

  2. A second update on mapping the human genetic architecture of COVID-19

    Nature

  3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

    BMC Health Services Research, Vol. 23, Núm. 1

  4. Clinical burden related to oral corticosteroid treatment of severe asthma in Spain: LEVANTE study

    Journal of Asthma, Vol. 60, Núm. 5, pp. 890-899

  5. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  6. Impact of Air Pollution on Asthma: A Scoping Review

    Open Respiratory Archives, Vol. 5, Núm. 2

  7. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

  8. Ten Issues for Updating in Community-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 21

2022

  1. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

    Human Molecular Genetics, Vol. 31, Núm. 23, pp. 3945-3966

  2. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity

    Archivos de Bronconeumologia, Vol. 58, Núm. 2, pp. 135-141

  3. Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 11-21

  4. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236

  5. Factors associated with clinical progression to severe COVID-19 in people with cystic fibrosis: A global observational study

    Journal of Cystic Fibrosis, Vol. 21, Núm. 4, pp. e221-e231

  6. Four-month incidence of suicidal thoughts and behaviors among healthcare workers after the first wave of the Spain COVID-19 pandemic

    Journal of Psychiatric Research, Vol. 149, pp. 10-17

  7. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

  8. Incidence and Prevalence of Children's Diffuse Lung Disease in Spain

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. 22-29

  9. Risk factors associated with pulmonary hypertension in obesity hypoventilation syndrome

    Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, Vol. 18, Núm. 4, pp. 983-992

  10. [Translated article] International consensus document on obstructive sleep apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 1, pp. T52-T68

2021

  1. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  2. International Consensus Document on Obstructive Sleep Apnea

    Archivos de Bronconeumologia